U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8313383133Prevalence of Metabolic Syndrome in Patients With Schizophrenia in KoreaNot yet recruitingNo Results AvailableSchizophrenia|Metabolic Syndromehttps://ClinicalTrials.gov/show/NCT01477918
8313483134Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of RemifentanilCompletedNo Results AvailableIntravenous Drug UsageDevice: Remi50 with prime|Device: Remi20 with primehttps://ClinicalTrials.gov/show/NCT01477905
8313583135Evaluation of Safety and Efficacy of Remifentanil in Pediatric PopulationCompletedHas ResultsInfant, PretermDrug: low dose remifentanilhttps://ClinicalTrials.gov/show/NCT01477892
8313683136Hsv 1 and 2 Gowey Protocol Versus PlaceboCompletedNo Results AvailableHerpesOther: Versabase gel with sarracenia purpurea 20% liquid extract|Other: placebo (versabase gel only)https://ClinicalTrials.gov/show/NCT01477879
8313783137Utility Of Citogenex Administration In Patients With Colon-Rectal CancerSuspendedNo Results AvailableColonic NeoplasmsDietary Supplement: citogenex|Other: conventional therapyhttps://ClinicalTrials.gov/show/NCT01477866
8313883138A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)TerminatedNo Results AvailableType 2 Diabetes MellitusDrug: Sitagliptin|Drug: Atorvastatin|Other: Placebo to sitagliptin|Other: Placebo to atorvastatin|Drug: Metformin|Drug: Glimepiride|Drug: Placebo to glimepiridehttps://ClinicalTrials.gov/show/NCT01477853
8313983139Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at CesareanNot yet recruitingNo Results AvailableBleeding IntraoperativeDrug: Misoprostolhttps://ClinicalTrials.gov/show/NCT01477840
8314083140Sunlight Exposure and Vitamin D in ChildrenCompletedNo Results AvailableHealthy SchoolchildrenOther: None - observational studyhttps://ClinicalTrials.gov/show/NCT01477827
8314183141Interventions to Improve Colon Cancer Screening in Poor Rural Iowa CountiesActive, not recruitingNo Results AvailableColorectal CancerBehavioral: Physician chart reminder|Behavioral: usual care|Behavioral: chart reminder, mailed education, FIT|Behavioral: chart reminder, mailed education, FIT, telephone callhttps://ClinicalTrials.gov/show/NCT01477814
8314283142Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D LevelsRecruitingNo Results AvailableHeart Failure|Vitamin D DeficiencyDrug: CHOLECALCIFEROL|Drug: PLACEBOhttps://ClinicalTrials.gov/show/NCT01477801
8314383143Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic MassWithdrawnNo Results AvailableOvarian Neoplasmhttps://ClinicalTrials.gov/show/NCT01477788
8314483144Customized Choice of Oral P2Y12 Receptor BlockerRecruitingNo Results AvailableAcute Coronary Syndrome|Coronary AngioplastyDrug: Oral P2Y12 receptor blocker|Drug: Customized choice for the oral P2Y12 receptor blockerhttps://ClinicalTrials.gov/show/NCT01477775
8314583145Cortisol Supression and Startle Responses in Posttraumatic Stress Disorder (PTSD)Active, not recruitingNo Results AvailablePTSDDrug: Dexamethasone|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01477762
8314683146Sipuleucel-T Manufacturing Demonstration StudyActive, not recruitingNo Results AvailableCancer of Prostate|Cancer of the Prostate|Neoplasms, Prostate|Neoplasms, Prostatic|Prostate Cancer|Prostate Neoplasms|Prostatic CancerBiological: sipuleucel-Thttps://ClinicalTrials.gov/show/NCT01477749
8314783147A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor OveractivityCompletedNo Results AvailableSpinal Cord InjuryDrug: Oxybutynin|Drug: Botulinum toxin Ahttps://ClinicalTrials.gov/show/NCT01477736
8314883148Evaluation of an Oral Nutritional Supplement in Older Hospitalized PatientsTerminatedNo Results AvailablePneumoniaOther: Experimental Oral Nutritional Supplementhttps://ClinicalTrials.gov/show/NCT01477723
8314983149Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a ModelCompletedHas ResultsPre-hospital VentilationProcedure: Hold mask|Procedure: Strap Mask|Procedure: Airwayhttps://ClinicalTrials.gov/show/NCT01477710
8315083150Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma PatientsTerminatedNo Results AvailableMultiple TraumaDietary Supplement: Omega-3|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01477697
8315183151Documentation of In-flight Medical Emergencies With Medical Incident Report Forms.CompletedNo Results AvailableIn-flight Medical Emergencyhttps://ClinicalTrials.gov/show/NCT01477684
8313183131Pattern of Statins Use in CataloniaCompletedNo Results AvailableHypercholesteremiahttps://ClinicalTrials.gov/show/NCT01477944
8315283152Prospective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenCompletedNo Results AvailableDengue|Dengue Fever|Dengue Hemorrhagic Feverhttps://ClinicalTrials.gov/show/NCT01477671
8313283132Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical FeaturesCompletedNo Results AvailableDepressive Disorder, MajorDrug: Bupropion extended releasehttps://ClinicalTrials.gov/show/NCT01477931
8315383153Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular BlockEnrolling by invitationNo Results AvailableCongenital Complete Atrioventricular Heart Block|High Grade Atrioventricular Block|Postoperative Complete Heart Blockhttps://ClinicalTrials.gov/show/NCT01477658
8315483154Health Effects Following Use of Lead Free Ammunition Used With HK416CompletedNo Results AvailableLung Function Tests|Markers of Inflammationhttps://ClinicalTrials.gov/show/NCT01477645
8315583155Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal WomenCompletedNo Results AvailableMenopause|HealthyDrug: 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)|Drug: 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA)|Drug: 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)https://ClinicalTrials.gov/show/NCT01477632
8315683156Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy SubjectsCompletedNo Results AvailableHealthy VolunteersDrug: Tasimelteonhttps://ClinicalTrials.gov/show/NCT01477619
8315783157Protocol in Acute Myeloid Leukemia With FLT3-ITDRecruitingNo Results AvailableAcute Myeloid LeukemiaDrug: Midostaurin|Drug: Cytarabine|Drug: Daunorubicinhttps://ClinicalTrials.gov/show/NCT01477606
8315883158Circumcision With a Novel Disposable Device in Chinese Children: a Hospital-based Randomized Controlled TrailCompletedNo Results AvailableCircumcisionProcedure: circumcision with Shenghuan in Yan's method|Procedure: circumcision with Shenghuan in Peng's method|Procedure: conventional method with incisionhttps://ClinicalTrials.gov/show/NCT01477593
8315983159Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)CompletedNo Results AvailableDengueBiological: Low-dose V180 with low-dose ISCOMATRIXâ„¢ adjuvant|Biological: Low-dose V180 with medium-dose ISCOMATRIXâ„¢ adjuvant|Biological: Medium-dose V180 (non-adjuvanted)|Biological: Medium-dose V180 with low-dose ISCOMATRIXâ„¢ adjuvant|Biological: Medium-dose V180 with medium-dose ISCOMATRIXâ„¢ adjuvant|Biological: Medium-dose V180 with Alhydrogelâ„¢ adjuvant|Biological: High-dose V180 (non-adjuvanted)|Biological: High-dose V180 with low-dose ISCOMATRIXâ„¢ adjuvant|Biological: High-dose V180 with medium-dose ISCOMATRIXâ„¢ adjuvant|Biological: Low-dose V180 with high-dose ISCOMATRIXâ„¢ adjuvant|Biological: Medium-dose V180 with high-dose ISCOMATRIXâ„¢ adjuvant|Biological: High-dose V180 with high-dose ISCOMATRIXâ„¢ adjuvant|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01477580
8316083160A First-in-Human Study of LY3009385 in Healthy ParticipantsCompletedHas ResultsDiabetes Mellitus, Type 2Drug: LY3009385|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01477567

* Görseller ve İçerik tekif hakkına sahip olabilir